Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MAP3K7CL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
SLC22A23 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
USP53 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMCC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DNAH14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GRB7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AHR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OVOL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC728613 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPP1R26 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
DPY19L2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FBXL16 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLIT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HLF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRUNE2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SPARCL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
H2BFXP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on